基本信息
浏览量:310
职业迁徙
个人简介
Dr. Hirsh is an international leader on the treatment of lung cancer, with over 120 scientific papers. For the past 10 years, her papers have been cited more than 1,700 times annually and her leading 5 papers on chemotherapy of lung cancer have been cited more than 12,000 times. Dr. Hirsh brought to McGill many of the cutting-edge modalities for treating lung cancer, allowing McGill’s teaching hospitals to be regular partners in prestigious lung cancer cooperative groups. When last counted 5 years ago she had participated in nearly 400 clinical trials, of which 80 were mainly for lung cancer therapy. A chemotherapy regimen for advanced lung cancer that became mainstream a few years ago in North America was called the “Hirsh” regimen. She is an international authority on management of adverse events from targeted therapies, quality of life in clinical trials, and patient-reported outcomes. Dr. Hirsh has lectured nationally and internationally and has been a regular keynote speaker at prestigious conferences, such as the European Society of Medical Oncology, American Society of Clinical Oncology, and the World Lung Cancer Conference. She was a prominent guideline development contributor for the International Association for the Study of Lung Cancer. Dr. Hirsh has been a most effective teacher and mentor to countless physicians, many of whom became oncology or respiratory medicine leaders in their own merit.
研究兴趣
论文共 258 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Jay Kumar Raghavan Nair, Umar Abid Saeed,Connor C McDougall,Ali Sabri,Bojan Kovacina, B V S Raidu, Riaz Ahmed Khokhar,Stephan Probst,Vera Hirsh,Chankowsky Jeffrey,Léon C Van Kempen,Jana Taylor
Journal of cancer research and clinical oncologyno. 6 (2019): 1569-1579
引用32浏览0引用
32
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn